[Remote] Senior Manager, Accounting at Abata Therapeutics

Remote

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Bachelor’s degree (B.A.) or equivalent required; MBA or CPA preferred
Experience working within a biotech / pharmaceutical company is strongly preferred
Experience working with public companies and/or public accounting experience
Experience supervising others in a direct line or dotted line function

Responsibilities

Manage monthly book closing activities such as preparation of journal entries, financial analyses, supporting documentation and financial statements
Assist with SEC reporting and technical accounting activities
Assist with management and execution of independent audit and Sarbanes-Oxley activities
Support the administration of share-based compensation programs
Manage collaboration arrangements
Assist with the oversight of all accounting functions including accounts receivable, accounts payable, general ledger, fixed assets, payroll, and purchasing
Assist with the preparation and analysis of accruals/prepaids for clinical trials, manufacturing and other research and development activities
Assist with the preparation of financial statements and other related reports including balance sheets, income statements, cash-flow reports, budgets, footnotes, and variance analysis
Assist with the activities related to the annual audit and quarterly reviews
Assist with the Sarbanes-Oxley activities including updating system documentation, testing controls, remediating control deficiencies and coordinating efforts with the internal and external auditors
Keep up to date on overall activities of the team, identifying problem areas and taking corrective actions
Assist with the implementation of accounting systems, policies, and procedures
Interview, hire, and train employees
Plan, assign, and direct work
Appraise performance
Reward and discipline employees
Address complaints and resolve problems
Other duties as assigned

Skills

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free